Risk factors are things that raise your chances of getting a disease. For each person, there’s a mix of genetic, biological and lifestyle factors that play a part in prostate cancer risk. About 1 in ...

About 1 in 8 men will be diagnosed with prostate cancer during their lifetime, and 1 in 44 will die of the disease, according to the American Cancer Society (ACS). Fortunately, prostate cancer is ...

RIB MOUNTAIN, Wis. (WSAW) - About one in eight men will be diagnosed with prostate cancer during their lifetime, according to the American Cancer Society. The best way to be among the millions of ...

Prostate cancer is one of the most common and serious health issues affecting men worldwide. In its early stages, the symptoms are often subtle or easily overlooked — making early detection ...

Randomized Trial Comparing Conventional-Dose With High-Dose Conformal Radiation Therapy in Early-Stage Adenocarcinoma of the Prostate: Long-Term Results From Proton Radiation Oncology Group/American ...

Follow this author to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this author to personalize your feed and get ...

Screening helps find prostate cancer early, when it is easiest to treat. Huntsman Cancer Institute is committed to improving prostate cancer outcomes through education and cutting-edge research to ...

A drug commonly used to treat type 2 diabetes has the added bonus of reducing the risk of prostate cancer, new research has found. For the study, published in Rejuvenation Research, researchers ...

FORMER PRESIDENT JOSEPH R. Biden has been diagnosed with Stage 4 prostate cancer, his office announced The cancer has spread to his bones, as it commonly does in more aggressive forms. It is generally ...

After skin cancer, prostate cancer is the most common type of cancer affecting men. It is a potentially aggressive and life-threatening disease that begins when cancerous cells form in the prostate—a ...

Researchers at Columbia University Irving Medical Center have identified a gene that drives the development of neuroendocrine prostate cancer (NEPC), an aggressive form of the disease. The study ...